These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18672491)

  • 1. U.S. Food and Drug Administration and off-label use of expandable metal biliary stents within the peripheral vasculature.
    Yustein AS; Schultz D; Neuland C; Buckles DS; Nipper JC; Stephenson RA; Gonzalez G
    J Vasc Interv Radiol; 2008 Jul; 19(7):965-9. PubMed ID: 18672491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label does not mean off-base.
    Kaufman JA
    J Vasc Interv Radiol; 2008 Jul; 19(7):970-1. PubMed ID: 18589309
    [No Abstract]   [Full Text] [Related]  

  • 3. US Food and Drug Administration and Off-Label Use of Metal Expandable Biliary Stents within the Peripheral Vasculature-Update.
    Marrone AK; Gottschalk L; Chen AL
    J Vasc Interv Radiol; 2020 Apr; 31(4):622-628. PubMed ID: 32094048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
    Ansel GM; Jaff MR
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malfunctions and adverse events associated with off-label use of biliary stents in the peripheral vasculature.
    Bridges J; Maisel WH
    Am J Ther; 2008; 15(1):12-8. PubMed ID: 18223348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements.
    Jones WS; Krucoff MW; Morales P; Wilgus RW; Heath AH; Williams MF; Tcheng JE; Marinac-Dabic JD; Malone ML; Reed TL; Fukaya R; Lookstein RA; Handa N; Aronow HD; Bertges DJ; Jaff MR; Tsai TT; Smale JA; Zaugg MJ; Thatcher RJ; Cronenwett JL
    J Vasc Surg; 2018 Feb; 67(2):637-644.e30. PubMed ID: 29389426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "criminalization" of off-label device use.
    White CJ
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):588-9. PubMed ID: 18819154
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulatory approval of peripheral endovascular revascularization devices in the United States: is the horse still in the barn?
    Weinberger J; Rundback JH; Ratchford EV
    Am J Ther; 2005; 12(2):186-91. PubMed ID: 15767839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ
    J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical-device safety and the FDA.
    Schultz DG
    N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction.
    Shim CS; Lee YH; Cho YD; Bong HK; Kim JO; Cho JY; Kim YS; Lee JS; Lee MS; Hwang SG; Shin KM
    Endoscopy; 1998 May; 30(4):345-50. PubMed ID: 9689506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
    Geraghty PJ; Matsumura JS; Conte MS
    J Vasc Surg; 2009 Dec; 50(6):1459-61. PubMed ID: 19897333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos).
    Park DH; Lee SS; Lee TH; Ryu CH; Kim HJ; Seo DW; Park SH; Lee SK; Kim MH; Kim SJ
    Gastrointest Endosc; 2011 Jan; 73(1):64-70. PubMed ID: 21184871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA's perspectives on cardiovascular devices.
    Chen EA; Patel-Raman SM; O'Callaghan K; Hillebrenner MG
    J Cardiovasc Transl Res; 2009 Jun; 2(2):143-6. PubMed ID: 20559979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA regulation of cardiovascular devices and opportunities for improvement.
    Dhruva SS; Redberg RF
    J Interv Card Electrophysiol; 2013 Mar; 36(2):99-105. PubMed ID: 23263896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semper fidelis--consumer protection for patients with implanted medical devices.
    Maisel WH
    N Engl J Med; 2008 Mar; 358(10):985-7. PubMed ID: 18322280
    [No Abstract]   [Full Text] [Related]  

  • 18. A surgeon's perspective regarding the regulatory, compliance, and legal issues involved with physician-modified devices.
    Starnes BW
    J Vasc Surg; 2013 Mar; 57(3):829-31. PubMed ID: 23446124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ongoing problems with metal-on-metal hip implants.
    Heneghan C; Langton D; Thompson M
    BMJ; 2012 Feb; 344():e1349. PubMed ID: 22374740
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the U.S. Food and Drug Administration in device evaluation and monitoring.
    ; Diehl DL; Tierney WM; Adler DG; Conway JD; Farraye FA; Kantsevoy SV; Kaul V; Kethu SR; Kwon RS; Mamula P; Pedrosa MC; Rodriguez SA
    Gastrointest Endosc; 2010 Jul; 72(1):5-10. PubMed ID: 20421100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.